Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,090 across all filing types
Latest filing 2022-11-02 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 97% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more during an M&A offer period. It details positions and dealings in the securities of Mediclinic International plc. This type of filing is a specific regulatory disclosure regarding shareholdings and dealings, which falls under the 'Major Shareholding Notification' category as it tracks significant ownership and changes in interest levels.
2022-11-02 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more during an offer period. It details positions and dealings in the securities of Mediclinic International plc by Citadel Group. Since this is a specific regulatory disclosure regarding shareholdings and dealings during a takeover/offer period, it falls under the 'Regulatory Filings' category as the most appropriate fallback for this type of mandatory market surveillance disclosure.
2022-11-01 English
Form 8.3 - Mediclinic International plc
Director's Dealing Classification · 98% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the opening position and dealing disclosures of a person with interests in relevant securities representing 1% or more of a company (Mediclinic International plc) involved in a takeover or merger scenario. This type of document is a specific regulatory requirement for transparency during M&A activity and does not fit into the other categories like 'M&A Activity' (which usually refers to company-issued announcements) or 'Director's Dealing' (which refers to company insiders). Therefore, it is classified as a Regulatory Filing.
2022-10-31 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 96% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details positions and dealings in securities during an M&A process. Since it does not fit into the specific categories of M&A activity (which usually refers to the company's own announcements) or other specific categories, it falls under the 'Regulatory Filings' (RNS) category as a standard disclosure document.
2022-10-28 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more during an M&A offer period. It details specific share dealings, derivative positions, and holdings in Mediclinic International plc. Since this is a mandatory regulatory disclosure regarding shareholdings and dealings during a takeover, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for company insiders) or 'Major Shareholding Notification' (which is for significant threshold crossings, whereas this is a specific Rule 8.3 disclosure).
2022-10-27 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details positions and dealings in the securities of Mediclinic International plc by Citadel Group. Since this is a specific regulatory disclosure regarding shareholdings and dealings during a takeover period, it falls under the 'Major Shareholding Notification' category, which covers notifications of significant ownership levels and related disclosures.
2022-10-26 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.